Mobile App

HTML clipboardTechNavio's analysts forecast the Global Central Nervous System Drugs market to grow at a CAGR of -3.2 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing size of aging population. The Global EEG/EMG Equipment market has also been witnessing the trend of novel molecules, launched to treat central nervous system disorders effectively. However, patent expiration of key drugs could pose a challenge to the growth of this market. http://www.bharatbook.com/healthcare-market-research-reports/global-central-nervous-system-drugs-market-2011-2015.html
 
 The Global Central Nervous System Drugs Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Central Nervous System Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
 
 Key vendors dominating this market space include AstraZeneca plc, Eli Lilly & Co., Johnson & Johnson Ltd., and Pfizer Inc. Other vendors mentioned in the report: Abbott Laboratories, Sanofi S.A., Bristol-Myers Squibb Co., Eisai Co. Ltd., UCB Pharma, Merck & Co. Inc., Schering-Plough Corp., Shire plc, and Cephalon Inc.
 
 Key questions answered in this report:
 What will the market size be in 2015 and at what rate will it grow?
 What key trends is this market subject to?
 What is driving this market?
 What are the challenges to market growth?
 Who are the key vendors in this market space?
 What are the opportunities and threats faced by each of these key vendors?
 What are the strengths and weaknesses of each of these key vendors?
 
 Table of Contents
 01. Executive Summary
 02. Introduction
 03. Market Coverage
 Overview
 Product Offerings
 04. Market Landscape
 Global Central Nervous System Drugs Market
 Market Size
 Key Market Segments
 04.1 Global Antipsychotics Market
 04.2 Global Antidepressants Market
 04.3 Global Antiepileptic Drugs Market
 04.4 Global Anti-Alzheimer's Drugs Market
 04.5 Global ADHD Drugs Market
 04.6 Global Hypnotics Market
 04.7 Global Anti-Parkinson's Drugs Market
 04.8 Global Antimigraine Drugs Market
 Segmentation of Global Central Nervous System Drugs Market
 Five Forces Analysis
 05. Geographical Segmentation
 06. Key Leading Countries
 USA
 Japan
 Germany
 07. Rate of Incidence and Prevalence
 08. Vendor Landscape
 Matrix of the Product Portfolio Matrix
 Vendor Landscape of the Leading CNS Drugs Market Segments
 08.1 Global Antipsychotics Market Segment
 08.2 Global Antidepressants Market Segment
 08.3 Global Antiepileptic Drugs Market Segment
 09. Buying Criteria
 10. Market Growth Drivers
 11. Drivers and their Impact
 12. Market Challenges
 13. Impact of Drivers and Challenges
 14. Market Trends
 15. Key Vendor Analysis
 15.1 Eli Lilly and Co.
 Business Overview
 SWOT Analysis
 15.2 Pfizer Inc.
 Business Overview
 SWOT Analysis
 15.3 AstraZeneca plc
 Business Overview
 SWOT Analysis
 15.4 Johnson and Johnson Ltd.
 Business Overview
 SWOT Analysis
 16. Other Reports in this Series
 
 For more information kindly visit :
 Global Central Nervous System Drugs Market 2011-2015
 
 Or
 
 Bharat Book Bureau
 Tel: +91 22 27810772 / 27810773
 Fax: + 91 22 27812290
 Email: info@bharatbook.com
 Website: www.bharatbook.com
 Follow us on twitter: http://twitter.com/#!/Sandhya3B
 Our Blogs: http://bharatbook.blogactiv.eu/
 http://healthcareraj.blogspot.com/